482 related articles for article (PubMed ID: 32951457)
21. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
22. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
[TBL] [Abstract][Full Text] [Related]
23. m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Zhang W; Wang L; Zhang P; Zhang Q
Medicine (Baltimore); 2021 May; 100(20):e25952. PubMed ID: 34011074
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and immunological characterization of RNA m
Wang Q; Zhang Q; Li Q; Zhang J; Zhang J
Mol Genet Genomic Med; 2021 Jan; 9(1):e1547. PubMed ID: 33225598
[TBL] [Abstract][Full Text] [Related]
25. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
[TBL] [Abstract][Full Text] [Related]
26. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
27. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
28. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
Li F; Zhang P
Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598
[TBL] [Abstract][Full Text] [Related]
29. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
30. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
Tang J; Wan Q; Lu J
BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
Front Immunol; 2021; 12():769425. PubMed ID: 34804059
[TBL] [Abstract][Full Text] [Related]
32. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
33. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
[TBL] [Abstract][Full Text] [Related]
34. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
Miao C; Fang X; Chen Y; Zhao Y; Guo Q
Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
[TBL] [Abstract][Full Text] [Related]
35. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
[TBL] [Abstract][Full Text] [Related]
36. m
Li G; Deng L; Huang N; Cui Z; Wu Q; Ma J; Pan Q; Sun F
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828353
[TBL] [Abstract][Full Text] [Related]
37. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
Fu Y; Sun S; Bi J; Kong C; Yin L
Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
[TBL] [Abstract][Full Text] [Related]
38. High expression of WTAP is related to poor prognosis in nasopharyngeal carcinoma.
Tao CJ; Zhang P; Chen YY; Chen M
Neoplasma; 2023 Apr; 70(2):229-239. PubMed ID: 36964720
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
40. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.
Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K
Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]